Smartkarma Research Team, Smartkarma

Smartkarma Research

Smartkarma Research Team

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

17LIVE Group Limited operates as a live streaming company. The Company offers pure-play live-streaming platform that streams real-time user-generated videos, as well as allows streamers to interact with their audience live via live chat or games, creating high-quality content. 17LIVE Group serves customers in Asia.

<p>For our next Corporate Webinar, we are glad to welcome 17Live’s Chief Executive Officer and Executive Director, Jiang Honghui. </p>
<p>In the upcoming webinar, Honghui will share a short company presentation after which, he will engage in a fireside chat with the Smartkarma moderator. The Corporate Webinar will include a live Q&amp;A session.</p>
<h3>The webinar will be hosted on Monday, 25 November 2024, 17:00 SGT/HKT.</h3>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<h2><a href="https://share.hsforms.com/1H9pFZOB-RF2J00kbvMmxcw2c5gj?zoom_webinar_id=81735174473" target="_blank" rel="noopener">Register for the Webinar here</a></h2>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<h3>About 17Live Group</h3>
<div>
<p>17LIVE is a leading pure-play live streaming platform in Asia with key markets in Japan and Taiwan. Its business lines include Liver live streaming, V-Liver live streaming and other businesses such as in-app games and live commerce. 17LIVE is accessible globally and has fostered a diverse live streaming ecosystem with a loyal and engaged user community, as well as a deep pool of live streamers.</p>
</div>

For our next Corporate Webinar, we are glad to welcome 17Live’s Chief Executive Officer and Executive Director, Jiang Honghui. 
In the upcoming webinar, Honghui will share a short company presentation after which, he will engage in a fireside chat with the Smartkarma moderator. The Corporate Webinar will include a live Q&amp;A session.
The webinar will be hosted on Monday, 25 November 2024, 17:00 SGT/HKT.



























Register for the Webinar here



























About 17Live Group

17LIVE is a leading pure-play live streaming platform in Asia with key markets in Japan and Taiwan. Its business lines include Liver live streaming, V-Liver live streaming and other businesses such as in-app games and live commerce. 17LIVE is accessible globally and has fostered a diverse live streaming ecosystem with a loyal and engaged user community, as well as a deep pool of live streamers.


Smartkarma Corporate Webinar | 17LIVE Group: Leading Pure-Play Live Streaming Platform in Asia

UMP Healthcare Holdings Ltd. offers healthcare solutions provider. The Company provides services for medical and dental needs. UMP serves both contract and plan customers.

<p>For our next Corporate Webinar, we are glad to welcome UMP Healthcare’s Chief Financial Officer and Company Secretary, Patrick Cheung. </p>
<p>In the upcoming webinar, Patrick will share a short company presentation after which, he will engage in a fireside chat with Smartkarma Insight Provider, <a href="https://www.smartkarma.com/profiles/sameer-taneja-a0539e0c-84dd-4e66-9c40-6e598edfb4c5/analysis" target="_blank" rel="noopener">Sameer Taneja</a>. The Corporate Webinar will include a live Q&amp;A session.</p>
<h3>The webinar will be hosted on Wednesday, 23 October 2024, 15:00 SGT/HKT.</h3>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div class="content-highlight">
<h2><a href="https://share.hsforms.com/1H9pFZOB-RF2J00kbvMmxcw2c5gj?zoom_webinar_id=81201150118" target="_blank" rel="noopener">Register for the Webinar here</a></h2>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<h3>About UMP Healthcare</h3>
<div>Founded in 1990, UMP Healthcare is a medical group listed on the main board of the Hong Kong Stock Exchange (stock code 722. HK) and is one of the leading comprehensive healthcare service platforms in the Hong Kong market. They are committed to "providing comprehensive, diversified, and coordinated care for everyone" by creating a network of high-quality and effective medical services for patients, payers, providers, and partners.</div>
<div> </div>
<div>Along with providing healthcare services that address a wide range of individual needs, UMP closely works with more than 2,000 local and international businesses and insurance organizations to establish and administer corporate healthcare benefit programs for members. The medical service network spans over 1,000 self-owned and affiliated institutions across Hong Kong, Macau, and Mainland China, offering services such as family medicine, specialist consultation, dental care, diagnostic imaging and laboratory testing, preventive medicine and health examination, physical therapy, day surgery, and endoscopy, among others. In 2024, the annual volume of outpatient visits under UMP exceeded 1.3 million.</div>

For our next Corporate Webinar, we are glad to welcome UMP Healthcare’s Chief Financial Officer and Company Secretary, Patrick Cheung. 
In the upcoming webinar, Patrick will share a short company presentation after which, he will engage in a fireside chat with Smartkarma Insight Provider, Sameer Taneja. The Corporate Webinar will include a live Q&amp;A session.
The webinar will be hosted on Wednesday, 23 October 2024, 15:00 SGT/HKT.



























Register for the Webinar here



























About UMP Healthcare
Founded in 1990, UMP Healthcare is a medical group listed on the main board of the Hong Kong Stock Exchange (stock code 722. HK) and is one of the leading comprehensive healthcare service platforms in the Hong Kong market. They are committed to "providing comprehensive, diversified, and coordinated care for everyone" by creating a network of high-quality and effective medical services for patients, payers, providers, and partners.
 
Along with providing healthcare services that address a wide range of individual needs, UMP closely works with more than 2,000 local and international businesses and insurance organizations to establish and administer corporate healthcare benefit programs for members. The medical service network spans over 1,000 self-owned and affiliated institutions across Hong Kong, Macau, and Mainland China, offering services such as family medicine, specialist consultation, dental care, diagnostic imaging and laboratory testing, preventive medicine and health examination, physical therapy, day surgery, and endoscopy, among others. In 2024, the annual volume of outpatient visits under UMP exceeded 1.3 million.

Smartkarma Corporate Webinar | UMP Healthcare: Undervalued Gem in Hong Kong's Healthcare Market

Kina Securities Limited provides banking and diversified financial services. The Company offers share brokerage, fund administration, investment management services, asset financing, and provision of personal and commercial loans, money market operations and corporate advice. Kina Securities operates in Papua New Guinea.

<p>For our next Corporate Webinar, we are glad to welcome Kina Bank's executive management to Smartkarma. <span style="font-size: var(--content-font-size);">In the upcoming webinar, they will share a short company presentation after which, they will engage in a fireside chat with Smartkarma Insight Provider, </span><a href="https://www.smartkarma.com/profiles/daniel-tabbush/research" target="_blank" data-smartkarma-citation="accounts:54017" rel="noopener">Daniel Tabbush</a><span style="font-size: var(--content-font-size);">. The Corporate Webinar will include a live Q&amp;A session.</span></p>
<h3>The Corporate Webinar will be hosted on Tuesday, 15 October 2024, 17:00 SGT.</h3>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div class="content-highlight">
<h2><a href="https://share.hsforms.com/1H9pFZOB-RF2J00kbvMmxcw2c5gj?zoom_webinar_id=81782992619" target="_blank" rel="noopener">Register for the Webinar here</a></h2>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<h3>About Kina Bank</h3>
<p>Kina Securities Limited (Kina Bank) was established in 1985 and is Papua New Guinea's<br>second largest bank and financial services company. Kina Bank offers customers end-to-end financial solutions – from savings accounts to business loans, investments to mortgages, financial advice and investment management. It is also the largest wealth management business in PNG, with more than PGK11 billion of funds under management. As the country’s largest fund administrator, they administer accounts on behalf of more than 938,000 beneficiaries whose funds total almost PGK19 billion. Kina Bank is also the leading stockbroking company in PNG and is listed on the Australian Securities Exchange (ASX:KSL) and the PNG’s Stock Exchange (PNGX:KSL). </p>

For our next Corporate Webinar, we are glad to welcome Kina Bank's executive management to Smartkarma. In the upcoming webinar, they will share a short company presentation after which, they will engage in a fireside chat with Smartkarma Insight Provider, Daniel Tabbush. The Corporate Webinar will include a live Q&amp;A session.
The Corporate Webinar will be hosted on Tuesday, 15 October 2024, 17:00 SGT.












Register for the Webinar here












About Kina Bank
Kina Securities Limited (Kina Bank) was established in 1985 and is Papua New Guinea's second largest bank and financial services company. Kina Bank offers customers end-to-end financial solutions – from savings accounts to business loans, investments to mortgages, financial advice and investment management. It is also the largest wealth management business in PNG, with more than PGK11 billion of funds under management. As the country’s largest fund administrator, they administer accounts on behalf of more than 938,000 beneficiaries whose funds total almost PGK19 billion. Kina Bank is also the leading stockbroking company in PNG and is listed on the Australian Securities Exchange (ASX:KSL) and the PNG’s Stock Exchange (PNGX:KSL). 

Smartkarma Corporate Webinar | Kina Bank: Rapidly Growing Bank from Papua New Guinea

RemeGen Co., Ltd. operates biotechnology businesses. The Company develops therapeutic antibody drugs such as antibody drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and double antibodies. RemeGen provides solutions autoimmune diseases, tumor diseases, and ophthalmic diseases.

<p>For our next Corporate Webinar, we are glad to welcome RemeGen's Chief Financial Officer, Mr. Tong Shaojing.</p>
<p>In the upcoming webinar, Tong will share a short company presentation after which, he will engage in a fireside chat with Smartkarma Insight Provider, <a href="https://www.smartkarma.com/profiles/eric-wen" target="_blank" data-smartkarma-citation="accounts:54017" rel="noopener">Eric Wen</a> . The Corporate Webinar will include a live Q&amp;A session.</p>
<h3>The Corporate Webinar will be hosted on Thursday, 19 September 2024, 09:00 SGT.</h3>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div class="content-highlight">
<h2><a href="https://share.hsforms.com/1H9pFZOB-RF2J00kbvMmxcw2c5gj?zoom_webinar_id=88131022121" target="_blank" rel="noopener">Register for the Webinar here</a></h2>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<h3>About RemeGen</h3>
<p>RemeGen was cofounded in 2008 by Mr. Wang Weidong, founder of Rongchang Pharmaceuticals, a leading traditional Chinese medicine company in China and Dr. Fang Jianmin, a Canadian-American scientist. Headquartered in the coastal city of Yantai Shandong Province of China, RemeGen has research labs and offices throughout China and the United States. RemeGen is committed to the discovery, development, and commercialization of innovative and differentiated biologic drugs of significant clinical value in the key therapeutic areas of autoimmune oncology and ophthalmic diseases.</p>

For our next Corporate Webinar, we are glad to welcome RemeGen's Chief Financial Officer, Mr. Tong Shaojing.
In the upcoming webinar, Tong will share a short company presentation after which, he will engage in a fireside chat with Smartkarma Insight Provider, Eric Wen . The Corporate Webinar will include a live Q&amp;A session.
The Corporate Webinar will be hosted on Thursday, 19 September 2024, 09:00 SGT.












Register for the Webinar here












About RemeGen
RemeGen was cofounded in 2008 by Mr. Wang Weidong, founder of Rongchang Pharmaceuticals, a leading traditional Chinese medicine company in China and Dr. Fang Jianmin, a Canadian-American scientist. Headquartered in the coastal city of Yantai Shandong Province of China, RemeGen has research labs and offices throughout China and the United States. RemeGen is committed to the discovery, development, and commercialization of innovative and differentiated biologic drugs of significant clinical value in the key therapeutic areas of autoimmune oncology and ophthalmic diseases.

Smartkarma Corporate Webinar | RemeGen: An Undervalued, Leading Biotech From China

Cross Asset Strategy

<div>
<section class="figure">
<section class="figure">
<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/429/721/original/Aex%20logo%202.png?1725445552" class="editor-image img-responsive" data-smartkarma-image-id="429721"></figure>
<p></p>
</section>
</section>
<p>In the next installment of our Webinar series, in collaboration with ASEAN Exchanges, we go live with Smartkarma Insight Provider <a href="https://www.smartkarma.com/profiles/shifara-samsudeen-acma-cgma/research" target="_blank" data-smartkarma-citation="accounts:1107" rel="noopener">Shifara Samsudeen</a>. </p>
<ul>
<li>The Initial Public Offering (IPO) market in the ASEAN region has experienced significant transformations over the past five years.</li>
<li>2023 was a year of uncertainty due to global supply chain disruptions, rising inflation, and geopolitical tensions, prompting investors to exercise caution.</li>
<li>As the region continues to navigate economic uncertainties and geopolitical challenges, the overall outlook remains cautiously optimistic, with potential for growth driven by strategic<br>reforms and sector-specific opportunities.</li>
</ul>
<p>Join us as Shifara Samsudeen shares her expert analysis on these developments, and what they mean for the future of the ASEAN region's IPO markets.</p>
</div>
<div>
<h3>The webinar will be hosted on Wednesday, 11 September 2024, 17:30 SGT/HKT.</h3>
</div>
<div>
<div>
<div>
<div>
<div>
<div class="content-highlight">
<h2><a href="https://www.smartkarma.com/home/webinar-registration-form/" target="_blank" rel="noopener">Register for the Webinar here</a></h2>
</div>
</div>
</div>
</div>
</div>
</div>
<div>
<p><a href="https://www.smartkarma.com/profiles/shifara-samsudeen-acma-cgma/research" target="_blank" data-smartkarma-citation="accounts:1107" rel="noopener">Shifara Samsudeen</a><a href="https://www.smartkarma.com/profiles/said-desaque" target="_blank" data-smartkarma-citation="accounts:1107" rel="noopener"></a> has over fifteen years of experience in investment research, with exposure to the tech and telecom sectors. She has extensive knowledge in performing industry deep dives and KPI identification along with advanced client services. Prior to joining LightStream Research, Shifara was an Assistant Director at Acuity Knowledge Partners (previously Moody’s Analytics Knowledge Services). Shifara is an Associate Member of CIMA – UK.</p>
</div>








In the next installment of our Webinar series, in collaboration with ASEAN Exchanges, we go live with Smartkarma Insight Provider Shifara Samsudeen. 

The Initial Public Offering (IPO) market in the ASEAN region has experienced significant transformations over the past five years.
2023 was a year of uncertainty due to global supply chain disruptions, rising inflation, and geopolitical tensions, prompting investors to exercise caution.
As the region continues to navigate economic uncertainties and geopolitical challenges, the overall outlook remains cautiously optimistic, with potential for growth driven by strategic reforms and sector-specific opportunities.

Join us as Shifara Samsudeen shares her expert analysis on these developments, and what they mean for the future of the ASEAN region's IPO markets.


The webinar will be hosted on Wednesday, 11 September 2024, 17:30 SGT/HKT.







Register for the Webinar here







Shifara Samsudeen has over fifteen years of experience in investment research, with exposure to the tech and telecom sectors. She has extensive knowledge in performing industry deep dives and KPI identification along with advanced client services. Prior to joining LightStream Research, Shifara was an Assistant Director at Acuity Knowledge Partners (previously Moody’s Analytics Knowledge Services). Shifara is an Associate Member of CIMA – UK.


Smartkarma Webinar | ASEAN IPO Capital Market Outlook: Cautious Optimism Amid Economic Uncertainties

Smartkarma Webinars
Broadcasting live from Smartkarma

Smartkarma Corporate Webinar | 17LIVE Group: Leading Pure-Play Live Streaming Platform in Asia

For our next Corporate Webinar, we are glad to welcome 17Live’s Chief Executive Officer and Executive Director, Jiang Honghui. In the upcoming...

Smartkarma Research

Smartkarma Corporate Webinar | UMP Healthcare: Undervalued Gem in Hong Kong's Healthcare Market

UMP Healthcare (722 HK) is one of the leading comprehensive healthcare service platforms in the Hong Kong market. Learn more about the company's...

Smartkarma Research

Smartkarma Corporate Webinar | Kina Bank: Rapidly Growing Bank from Papua New Guinea

Kina Bank is Papua New Guinea's second largest bank and financial services company, dual-listed on the Australian (ASX:KSL) and PNG (PNGX:KSL)...

Smartkarma Research

Smartkarma Corporate Webinar | RemeGen: An Undervalued, Leading Biotech From China

RemeGen (9995 HK) is a leading biotech company committed to the discovery, development, and commercialization of innovative biologic drugs. Learn...

Smartkarma Research

Smartkarma Webinar | ASEAN IPO Capital Market Outlook: Cautious Optimism Amid Economic Uncertainties

Join Shifara Samsudeen in our upcoming webinar, where she will delve into the recent transformations of the ASEAN IPO market and what the future...

Smartkarma Research